Distinct Muscarinic Receptor Subtypes Differentially Modulate Acetylcholine Release from Corticocerebral Synaptosomes
- 1 August 1990
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 55 (2) , 665-672
- https://doi.org/10.1111/j.1471-4159.1990.tb04185.x
Abstract
The effect of McN-A-343 and oxotremorine on acetylcholine (ACh) release and choline (Ch) transport was studied in corticocerebral synaptosomes of the guinea pig. The synaptosomes were preloaded with [3H]Ch after treatment with the irreversible cholinesterase inhibitor, diisopropyl fluorophosphate, and then tested for their ability to release isotope-labeled ACh and Ch in the presence and absence of these agents. The kinetics of release were determined at the resting state (based release) and in the presence of 50 mM K+. Under either condition, McN-A-343 enhanced the release of isotope-labeled ACh whereas oxotremorine inhibited the K+-evoked release but had no effect on the basal release. The enhancing effect of McN-A-343 on basal ACh release was fully blocked by the selective M1 muscarinic antagonist, pirenzepine (100 nM). In contrast to its enhancing effect on ACh release, McN-A-343 potently inhibited Ch efflux as well as Ch influx. These effects were not blocked by atropine, a nonselective muscarinic antagonist. Oxotremorine had no effect on Ch transport. Binding studied showed that McN-A-343 was 3.6-fold more potent in displacing randiolabeled quinuclidinyl benzilate from cerebral cortex muscarinic receptors (mostly M1 subtype) than from cerebellar receptors (mostly M2 subtype), whereas oxotremorine was 2.6-fold more potent in the cerebellum. The displacements of radio-labeled pirenzepine and cis-dioxolane confirmed the M1 subtype preference of McN-A-343 and the M2 subtype preference of oxotremorine. These observations suggest that (a) activation of one subpopulation of muscarinic receptors by McN-A-343 enhances ACh release, whereas activation of another subpopulation by oxotremorine decrease this process (these subpopulations may correspond to the M1 and M2 subtypes, respectively), (b) the effect of the stimulatory receptors is pronounced at the resting state and that of the inhibitory receptors during depolarization, and (c) activation of the stimulatory receptors may be inversely related to the activity of the Ch transporter.Keywords
This publication has 33 references indexed in Scilit:
- Presynaptic M1 muscarinic receptor modulates spontaneous release of acetylcholine from rat basal forebrain slicesNeuroscience Letters, 1988
- Reversible and Irreversible Inhibition of High‐Affinity Choline Transport Caused by Ethylcholine Aziridinium IonJournal of Neurochemistry, 1987
- Differential interactions of muscarinic drugs with binding sites of [ 3 H]pirenzepine and [ 3 H]quinuclidinyl benzilate in rat brain tissueLife Sciences, 1987
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- Cholinergic Modulation of the Release of [3H]Acetylcholine from Synaptosomes of the Myenteric PlexusJournal of Neurochemistry, 1982
- The Effect of Acetylcholine Release on Choline Fluxes in Isolated Synaptic TerminalsJournal of Neurochemistry, 1981
- Choline inhibits acetylcholine release via presynaptic muscarine receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Muscarinic autoreceptor regulates acetylcholine release in rat hippocampus: in vitro evidenceActa Physiologica Scandinavica, 1980
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973